Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Katharina Bierman"'
Autor:
Carlijn A M Roumans, Manon C W Spaander, Iris Lansdorp-Vogelaar, Katharina Biermann, Marco J Bruno, Ewout W Steyerberg, Dimitris Rizopoulos, ProBar study group
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0267503 (2022)
ObjectivesThe current surveillance strategy in Barrett's esophagus (BE) uses only histological findings of the last endoscopy to assess neoplastic progression risk. As predictor values vary across endoscopies, single measurements may not be an accura
Externí odkaz:
https://doaj.org/article/883d06afc9034f7a80a707a0a6c55f3f
Autor:
Mark Shannon, Hans Stoop, Leendert H. J. Looijenga, Wolter Oosterhuis, Astrid Ferlinz, Katharina Bierman, Elana Swartzman, Ad J. M. Gillis
Publikováno v:
Cancer Research. 70:1163-1163
Human testicular germ cell tumors (TGCTs) are the most frequent solid cancer in Caucasian males between the ages of 15 and 45 years. In spite of the high success rate of current treatment strategies (surgery, irradiation and chemotherapy), TGCTs are
Autor:
Priscilla A. van Riet, Rutger Quispel, Djuna L. Cahen, Mieke C. Snijders-Kruisbergen, Petri van Loenen, Nicole S. Erler, Jan-Werner Poley, Lydi M. J. W. van Driel, Sanna A. Mulder, Bart J. Veldt, Ivonne Leeuwenburgh, Marie-Paule G. F. Anten, Pieter Honkoop, Annemieke Y. Thijssen, Lieke Hol, Mohammed Hadithi, Claire E. Fitzpatrick, Ingrid Schot, Jilling F. Bergmann, Abha Bhalla, Marco J. Bruno, Katharina Biermann
Publikováno v:
Endoscopy International Open, Vol 08, Iss 02, Pp E155-E162 (2020)
Background and study aims The traditional “smear technique” for processing and assessing endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is sensitive to artifacts. Processing and evaluation of specimens collected in a liquid medium,
Externí odkaz:
https://doaj.org/article/9ce7cf0abf214efeaa2e789abaf5f5b2
Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples
Autor:
Anna M. J. van Nistelrooij, Ronald van Marion, Linetta B. Koppert, Katharina Biermann, Manon C. W. Spaander, Hugo W. Tilanus, J. Jan B. van Lanschot, Bas P. L. Wijnhoven, Winand N. M. Dinjens
Publikováno v:
BMC Research Notes, Vol 10, Iss 1, Pp 1-7 (2017)
Abstract Background Intratumor heterogeneity has been demonstrated in several cancer types, following a model of branched evolution. It is unknown to which extent intratumor heterogeneity is applicable to esophageal adenocarcinoma. Therefore the aim
Externí odkaz:
https://doaj.org/article/d45cf8eebed04d518a7c2b0cc21d8731
Autor:
Lucia Suzuki, Fiebo J C Ten Kate, Annieke W Gotink, Hans Stoop, Michail Doukas, Daan Nieboer, Manon C W Spaander, Jan J B van Lanschot, Bas P L van Wijnhoven, Arjun D Koch, Marco J Bruno, Leendert H J Looijenga, Katharina Biermann
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219494 (2019)
To date no informative biomarkers exist to accurately predict presence of lymph node metastases (LNM) in esophageal adenocarcinoma (EAC). We studied the discriminative value of Olfactomedin 4 (OLFM4), an intestinal stem cell marker, in EAC. Patients
Externí odkaz:
https://doaj.org/article/b4c452dc87ab4dae9827957a23a56e19
Autor:
Kostandinos Sideras, Katharina Biermann, Joanne Verheij, Bart R. Takkenberg, Shanta Mancham, Bettina E. Hansen, Hannah M. Schutz, Robert A. de Man, Dave Sprengers, Sonja I. Buschow, Maddy C. M. Verseput, Patrick P. C. Boor, Qiuwei Pan, Thomas M. van Gulik, Turkan Terkivatan, Jan N. M. Ijzermans, Ulrich H. W. Beuers, Stefan Sleijfer, Marco J. Bruno, Jaap Kwekkeboom
Publikováno v:
OncoImmunology, Vol 6, Iss 2 (2017)
Novel systemic treatments for hepatocellular carcinoma (HCC) are strongly needed. Immunotherapy is a promising strategy that can induce specific antitumor immune responses. Understanding the mechanisms of immune resistance by HCC is crucial for devel
Externí odkaz:
https://doaj.org/article/5f8e3ae8e9ab4fa2a3ac206ae24b7197
Autor:
Robert R J Coebergh van den Braak, Anieta M Sieuwerts, Raju Kandimalla, Zarina S Lalmahomed, Sandra I Bril, Anne van Galen, Marcel Smid, Katharina Biermann, J Han J M van Krieken, Wigard P Kloosterman, John A Foekens, Ajay Goel, John W M Martens, Jan N M IJzermans, MATCH study group
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0185607 (2017)
Overall and splice specific expression of Spleen Tyrosine Kinase (SYK) has been posed as a marker predicting both poor and favorable outcome in various epithelial malignancies. However, its role in colorectal cancer is largely unknown. The aim of thi
Externí odkaz:
https://doaj.org/article/a097a63dc8464cf5aefb121a394995f8
Autor:
Maarten G. Thomeer, Mirelle E. E. Bröker, Quido de Lussanet, Katharina Biermann, Roy S. Dwarkasing, Rob de Man, Jan N. IJzermans, Marianne de Vries
Publikováno v:
Diagnostic and Interventional Radiology, Vol 20, Iss 3, Pp 193-199 (2014)
Hepatocellular adenoma (HCA) is a generally benign liver tumor with the potential for malignancy and bleeding. HCAs are categorized into four subtypes on the basis of genetic and pathological features: hepatocyte nuclear factor 1α-mutated HCA, β-ca
Externí odkaz:
https://doaj.org/article/3967a6a90c33427fa291484aad682413
Autor:
Ronak Eini, Hans Stoop, Ad J M Gillis, Katharina Biermann, Lambert C J Dorssers, Leendert H J Looijenga
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e83585 (2014)
The transcription factor SOX2, associated with amongst others OCT3/4, is essential for maintenance of pluripotency and self-renewal of embryonic stem cells. SOX2 is highly expressed in embryonal carcinoma (EC), the stem cell component of malignant no
Externí odkaz:
https://doaj.org/article/9fac1303bc01499dbec9b0b45660e11e
Autor:
Remko Hersmus, Hans Stoop, Gert Jan van de Geijn, Ronak Eini, Katharina Biermann, J Wolter Oosterhuis, Catharina Dhooge, Dominik T Schneider, Isabelle C Meijssen, Winand N M Dinjens, Hendrikus Jan Dubbink, Stenvert L S Drop, Leendert H J Looijenga
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e43952 (2012)
Activating c-KIT mutations (exons 11 and 17) are found in 10-40% of testicular seminomas, the majority being missense point mutations (codon 816). Malignant ovarian dysgerminomas represent ~3% of all ovarian cancers in Western countries, resembling t
Externí odkaz:
https://doaj.org/article/4efb1ae9688648e4b31b0fd70aa1e94c